Heres what unfolded after Schuyler submitted the online quizzes: Hersa womens telehealth company that launched in 2018 with a focus on sexual wellness and skincare and has since become better known for offering weight loss drugswarned me that my prescription would not be evaluated for safety, effectiveness, or quality by the FDA. It asked me harrowing questions such as, How disruptive would vomiting, constipation, and diarrhea be to your daily life? And then, thank God, Hers told me I didnt qualify
This disrupts the function of L-cells, reducing the release of GLP-1 and leading to poor glucose metabolism
Your healthcare team can advise you on this
Most patients experience weight regain after discontinuing GLP-1 therapy, as obesity is a chronic condition requiring ongoing management
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across three commitment tiers, with the assurance that your dose may need to go up as you progress, but your price won't
This novel treatment, nearing Phase 1 clinical trials, could help prevent weight regain post-GLP-1 analogue use by mimicking the incretin hormone to suppress appetite and regulate blood sugar, thus aiding in the management of obesity and diabetes.